LENMED AIR 2019.pdf

Report of the Audit and Risk Committee in terms of section 94(7)(f) of the Companies Act. The committee met on five occasions during the period under review and held further discussions with the external and internal auditors. Based on the information supplied at those meetings, the audit committee has no reason to believe that there were any material failures or breakdowns in the system design and effectiveness of internal financial controls during the year. The committee also satisfied itself on the independence of the external auditor and that they were properly appointed in terms of the Companies Act. The committee reviewed the consolidated annual financial statements and the annual integrated report as well as the significant judgements and reporting decisions with the assurance providers and management and came to the conclusions that: In terms of section 88(2) of the Companies Act No 71 of 2008, as amended, I, W. SOMERVILLE, the under signed, being the Company Secretary of Lenmed Investments Limited, certify that, to the best of my knowledge and belief, the Company has lodged with the Companies and Intellectual Property Commission, for the financial year 28 February 2019, all such returns required by a public company in terms of the Companies Act No 71 of 2008, as amended, and that all such returns are true, correct and up to date. Mr W Somerville Company Secretary 28 May 2019 Report of the Audit and Risk Committee Statement of compliance by the Company Secretary + The going concern basis of reporting is appropriate. + The annual financial statements and integrated report comply in all material respects with statutory disclosure requirements. + The consolidated annual financial statements should be approved by the board and circulated to shareholders. For further information on the composition and activities of the audit committee, please refer to the annual integrated report. Mr M G Meehan CA (SA) Chairman of the Audit Committee 22 May 2019 LENMED ANNUAL INTEGRATED REPORT 2019 85